These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 25008774)

  • 81. A Near-Infrared Laser-Triggered Size-Shrinkable Nanosystem with In Situ Drug Release for Deep Tumor Penetration.
    Wu D; Xu S; Zhang X; Li Y; Zhang W; Yan Q; Yang Q; Guo F; Yang G
    ACS Appl Mater Interfaces; 2021 Apr; 13(14):16036-16047. PubMed ID: 33733732
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Recent advances in drug delivery: potential and limitations of carbon nanotubes.
    Prakash S; Kulamarva AG
    Recent Pat Drug Deliv Formul; 2007; 1(3):214-21. PubMed ID: 19075888
    [TBL] [Abstract][Full Text] [Related]  

  • 83. MEMS fabricated chip for an implantable drug delivery device.
    Sbiaa Z
    Conf Proc IEEE Eng Med Biol Soc; 2006; 2006():5621-4. PubMed ID: 17947154
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Application of the near-infrared spectroscopy in the pharmaceutical technology.
    Jamrógiewicz M
    J Pharm Biomed Anal; 2012 Jul; 66():1-10. PubMed ID: 22469433
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Tetherless near-infrared control of brain activity in behaving animals using fully implantable upconversion microdevices.
    Wang Y; Lin X; Chen X; Chen X; Xu Z; Zhang W; Liao Q; Duan X; Wang X; Liu M; Wang F; He J; Shi P
    Biomaterials; 2017 Oct; 142():136-148. PubMed ID: 28735174
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Microporation applications for enhancing drug delivery.
    Banga AK
    Expert Opin Drug Deliv; 2009 Apr; 6(4):343-54. PubMed ID: 19348604
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Chronopharmaceutics: as a clinically relevant drug delivery system.
    Gandhi BR; Mundada AS; Gandhi PP
    Drug Deliv; 2011 Jan; 18(1):1-18. PubMed ID: 21138394
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Near-infrared light remote-controlled intracellular anti-cancer drug delivery using thermo/pH sensitive nanovehicle.
    Qin Y; Chen J; Bi Y; Xu X; Zhou H; Gao J; Hu Y; Zhao Y; Chai Z
    Acta Biomater; 2015 Apr; 17():201-9. PubMed ID: 25644449
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Predicting the tissue depth for remote triggering of drug delivery systems.
    Rwei AY; Wang B; Ji T; Kohane DS
    J Control Release; 2018 Sep; 286():55-63. PubMed ID: 30030183
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Recent Advances of Using Hybrid Nanocarriers in Remotely Controlled Therapeutic Delivery.
    Li Z; Ye E; David ; Lakshminarayanan R; Loh XJ
    Small; 2016 Sep; 12(35):4782-4806. PubMed ID: 27482950
    [TBL] [Abstract][Full Text] [Related]  

  • 91. On-demand delivery of protein drug from 3D-printed implants.
    Kim D; Wu Y; Oh YK
    J Control Release; 2022 Sep; 349():133-142. PubMed ID: 35787916
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Near-infrared light for on-demand drug delivery.
    Lim DJ; Park H
    J Biomater Sci Polym Ed; 2018; 29(7-9):750-761. PubMed ID: 29082832
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Recent advances in pharmaceutical dosage forms and devices using additive manufacturing technologies.
    Gioumouxouzis CI; Karavasili C; Fatouros DG
    Drug Discov Today; 2019 Feb; 24(2):636-643. PubMed ID: 30503803
    [TBL] [Abstract][Full Text] [Related]  

  • 94. 2008 Editors' Collection.
    Gumbleton M
    Adv Drug Deliv Rev; 2008 Dec; 60(15):1569. PubMed ID: 18951933
    [No Abstract]   [Full Text] [Related]  

  • 95. Microneedle-based drug delivery: studies on delivery parameters and biocompatibility.
    Wu Y; Qiu Y; Zhang S; Qin G; Gao Y
    Biomed Microdevices; 2008 Oct; 10(5):601-10. PubMed ID: 18324474
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Oral osmotically driven systems: 30 years of development and clinical use.
    Malaterre V; Ogorka J; Loggia N; Gurny R
    Eur J Pharm Biopharm; 2009 Nov; 73(3):311-23. PubMed ID: 19602438
    [TBL] [Abstract][Full Text] [Related]  

  • 97. The role of intracochlear drug delivery devices in the management of inner ear disease.
    Ayoob AM; Borenstein JT
    Expert Opin Drug Deliv; 2015 Mar; 12(3):465-79. PubMed ID: 25347140
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Upconverting nanoparticles with a mesoporous TiO₂ shell for near-infrared-triggered drug delivery and synergistic targeted cancer therapy.
    Yin M; Ju E; Chen Z; Li Z; Ren J; Qu X
    Chemistry; 2014 Oct; 20(43):14012-7. PubMed ID: 25200923
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Drug targeting by retrometabolic design: soft drugs and chemical delivery systems.
    Bodor N; Buchwald P
    J Recept Signal Transduct Res; 2001; 21(2-3):287-310. PubMed ID: 11757686
    [No Abstract]   [Full Text] [Related]  

  • 100. Process analytical technologies and injectable drug products: Is there a future?
    Henriques J; Sousa J; Veiga F; Cardoso C; Vitorino C
    Int J Pharm; 2019 Jan; 554():21-35. PubMed ID: 30389475
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.